Effectiveness of ozonation in decomposition of clofibric acid and bisphenol a in model water solutions

Zacharska, E.; Odrzywolski, A.; Depta, M.; Ozonek, J.

Artykuł - szczegóły

Tytuł artykułu

Effectiveness of ozonation in decomposition of clofibric acid and bisphenol a in model water solutions

Autorzy

Zacharska E. , Odrzywolski A. , Depta M. , Ozonek J.

Treść / Zawartość

Pełne teksty:

httpwww_ceer_uz_zgora_plcrfilearchive4f1953ba67e0c91443a6b9ca8b709cd5.pdf

Pobierz

Identyfikatory

Warianty tytułu

Skuteczność ozonowania w rozkładzie kwasu klofibrowego i bisfenolu A w modelowych roztworach wodnych

Języki publikacji

Abstrakty

The article contains a brief characteristic of the compounds counted among PPCPs (Pharmaceuticals and Personal Care Products) and EDCs (Endocrine Disrupting Compounds) along with the presentation of their removal methods used in typical WWTPs (Wastewater Treatment Plants), WTPs (Water Treatment Plants) as well as different methods examined in laboratory conditions. The article also shows the results of the tests on decomposition of the selected compounds (clofibric acid, bisphenol A) in model water solutions with the use of advanced oxidation technique - ozonation. The compounds were selected because of their commonness and large volume of production. The main purpose of the research is to design an appropriate equipment generating ozone that could be used in a technical scale. The mechanisms of the compounds migration as well as their sources in the environment are described in the article. Further studies concerning identification of the by products of these compounds decomposition as well as recognition of the precise mechanisms occurring during different methods application need to be examined in the future.

Artykuł zawiera krótką charakterystykę związków zaliczanych do grupy PPCP (Farmaceutyki i produkty pielęgnacyjne) i EDC (związki endokrynnie czynne) wraz z przedstawieniem metod ich usuwania stosowanych w typowych zakładach oczyszczalni ścieków, stacjach uzdatniania wody jak również opisem innych metod analizowanych w warunkach laboratoryjnych. Artykuł przedstawia także wyniki badań rozkładu wybranych związków (kwas klofibrowy, bisfenol A) w modelowych roztworach wodnych przy użyciu zaawansowanej techniki utleniania - ozonowania. O wyborze związków do badań zadecydowała głównie ich powszechność występowania oraz znaczna produkcja. Głównym celem badań jest zaprojektowanie odpowiedniej aparatury wytwarzającej ozon, która może być zastosowana na skalę techniczną. Dodatkowo w artykule opisano mechanizmy migracji tych związków wraz z określeniem ich źródeł w środowisku. Dalsze etapy badań obejmują identyfikację produktów pośrednich rozkładu analizowanych związków, a także poznanie dokładnego mechanizmu zachodzącego podczas stosowania różnych metod degradacji.

Słowa kluczowe

PPCPs clofibric acid ozonation

związki PPCP ozonowanie

Wydawca

Oficyna Wydawnicza Uniwersytetu Zielonogórskiego

Czasopismo

Civil and Environmental Engineering Reports

Rocznik

2010

Tom

No. 4

Strony

69--88

Opis fizyczny

Bibliogr. 61 poz., rys., tab.

Twórcy

autor

Zacharska E.

Lublin University of Technology, Faculty of Enviromental Engineering

autor

Odrzywolski A.

Lublin University of Technology, Faculty of Enviromental Engineering

autor

Depta M.

Lublin University of Technology, Faculty of Enviromental Engineering

autor

Ozonek J.

Lublin University of Technology, Faculty of Enviromental Engineering

Bibliografia

1. AHERNE G.W., BRIGGS F.: The Relevance of the Presence of Certain Synthetic Steroids in the Aquatic Environment. J. Pharm. Pharmacol. 41, 735-735 (1989).
2. ANDREOZZI R., CAPRIO V., MAROTTA R., RADOVNIKOVIC A.J.: Ozonation and H2O2/UV Treatment of Clofibric Acid in Water: A Kinetic Investigation. Hazard Mater., 103:233-246 (2003a).
2a. ANDREOZZI R., MAROTTA R., PAXEUS N.: Pharmaceuticals in STP Effluents and Their Solar Photodegradation in Aquatic Environment. Chemosphere 50: 1319 1330 (2003c).
3. ASHTON, D., HILTON,M., THOMAS, K.V., 2004. Sci. Total Environ. 333, 167-184.
4. BARCELO D.: Emerging Pollutants in Water Analysis. Trace-trend, Anal. Chem. 22, XIV-XVI (2003).
5. BRAGHETTA A. H., GILLOGLY B., BROWNAWELL B., BENOTTI M.: Removal of Pharmaceuticals and Endocrine Disrupting Compunds Through Advanced Wastewater Treatment Technologies. Water Quality and Technology Conference. Seattle, Washington, DC (November 2002).
6. CAMPBELL C.G., BORGLIN S.E., GRENN F.B., GRAYSON A., WOZEI E., STRINGFELLOW W.T.: Biologically Directed Environmental Monitoring: Fate and Transport of Estrogenic Endocrine Disrupting Compounds in Water: A Review. Chemosphere 65, 1265-1280 (2006).
7. CARLSON M.: Current and Emerging Drinking Water Treatment Technologies. Presentation at the Endocrine Disruptors and Pharmaceutically Active Chemicals in Drinking Water Workshop, Chicago, Illinois (April 2000).
8. CHANG S., JANG N.J., WAITE T.D., FANE A.C.: A Simplified Model for Trace Organics Removal by Continuous Flow PAC Adsorption/Submerged Membrane Processes. J.Membr.Sci. 253 (1-2), 155-163 (2009).
9. CHANG S.J., JANG N.J., YED Y.H., RIM I.S.: Fate and Transport of Endocrine-Disrupting Compounds (Oestrorte and 17β-Oestradiol) in a Membrane Bio-Reactor Used for Water Re-Use. Water Sci.Technol. 53 (9), 123-130 (2006).
10. COMERTON A.M., ANDREWS R.C., BAGLEY D.M., HAO C.Y.: The Rejection of Endocrine Disrupting and Pharmaceutically Active Compounds by NI and RO Membranes as a Function of Compound a Water Matrix Properties. J.Membr.Sci. 313 (1-2), 323-335 (2008).
11. COMERTON A.M., ANDREWS R.C., BAGLEY D.M., YANG P.: Membrane Adsorption of Endocrine Disrupting Compounds and Pharmaceutically Active Compounds. J. Membr. Sci. 303 (1-2), 267-277 (2007).
12. DALINGA J.W., MOONEN J.C., DUMOULIN J.C.M., EVERS J.I.C., GERAEDTS J.P.M., KLEINJANS J.C.S.: Decreasing Human Semen Quality and Organochlorine Compounds in Blood. Hum. Repr. 17, 1973-1979 (2002).
13. FORREZ I., CARBALLA M., NOPPE H., DE BRABANDER H., BOON N., VERSTRAETE W.: Influence of Manganese and Ammonium Oxidation on the Removal of 17α-Ethinyleestradiol (EE2). Water Res. 43 (1), 77-86 (2009).
14. HEBERER T.: Occurrence, Fate and Removal of Pharmaceutical Residues in the Aquatic Environment: A Review of Recent Research Data. Toxicol. Lett., 131:5-17 (2002).
15. HECKER M., HOLLERT H., COOPER R., VINGAARD A.M., AKAHORI Y., MURPHY M., NELLEMMAN C., HIGLEY E., NEWSTED J., WU R., LAM O., LASKEY J., BUCKALEW A., GRUND S., NAKAI M., TIMIN G., GIESY J.: The OECD Validation Program of the H295R Steroidgenesis Assay for the Identification of in vitro Inhibitors and Inducers of Testosterone and Estradiol Production. Phase 2: Interlaboratory Pre-validation Studies. Environ.Sci. Pollut. Res. 14 (1) 23-30 (2007).
16. HIGNITE C., AZARNOFF D.L.: Drugs and Drug Metabolites as Environmental Contaminants: Chlorophenoxyisobutytate and Salicylic Acid in Sewage Water Effluent. Life Sci.20, 337-341 (1977).
17. HUBER M. M., CANONICA S., PARK G. -Y., AND GUNTEN U.: Oxidation of Pharmaceuticals During Ozonation and Advanced Oxidation Processes. Environ. Sci. Technol., 37: 1016-1024 (2003).
18. INUMARU K., KIYOTO J., YAMANAKA S.: Molecular Selective Adsorption of Nonylphenol in Aqeous Solution by Organo-Functionalized Mesoporous Silica. Chem. Commun. 903-904 (2006).
19. JORGENSEN, S.E., HALLING-SORENSEN, B., Chemosphere, 40, 691, (2000).
20. JOSS A., KELLER E., ALDER A.C., GOBEL A., MCARDELL C.S., TERNES T., SIEGRIST H.: Removal of Pharmaceuticals and Fragrances in Biological Wastewater Treatment. Water Res. 39, 3139-3152 (2005).
21. KAGLE J., PORTER A.W., MURDOCH A.W., RIVERA-CANCEL G., HAY A.G.: Biodegradation of Pharmaceutical and Personal care Products. Adv. Appl. Microbiol. 67, 65-108 (2009).
22. KASPRZYK-HORDERN B., DINSDALE R.M., GUWY A.J.: The Removal of Pharmaceuticals, Personal Care Products, Endocrine Disruptors and Illicit Drugs during Wastewater Treatment and its Impact on the Quality of Receiving Waters. Water Research, 43,363-380, 2009.
23. KAVANAGH R. J., BALCH G. C., KIPARISSIS Y., NIIMI A. J., SHERRY J., TINSON C., METCALFE C. D.: Endocrine Disruptors and Altered Gonadal Development in White Perch (Morone Americana) From the Lower Great Lakes Region. Environ. Health Perspect., 112:898-902. (2004).
24. KHAN S. J., ONGERTH J.E.: Estimation of Pharmaceutical Residues in Primary and Secondary Sewage Sludge Base on Quantities of Use and Fugacity Modeling. Water Sci. Technol. 46, 105-113, (2002b).
25. KIK S. D., CHO J., KIM I. S., VANDERFORD B. J., SNYDER S.A.: Occurrence and Removal of Pharmaceuticals and Endocrine Disruptors in South Korean Surface, Drinking and Waste Waters. Water Res. 41, 1013-1021 (2007).
26. KIM J.H, PARK P.K., LEE C.H., KWON H.H., LEE S.: A Novel Hybrid System for the Removal of Endocrine Disrupting Chemicals: Nanofiltration and Homogeneous Catalytic Oxidation. J. Membr. Sci. 312 (1-2), 66-75 (2008).
27. KIM J.H., KIM S.J., LEE C.H., KWON H.H.: Removal of Toxic Organic Micropollutants with FeTsPc-Immobilized Amberlite/H2O2: Effect of Physicochemical Properties of Toxic Chemicals. Ind.Eng.Chem.Res. 48 (3) 1586-1592 (2009).
28. KIM J.H., PARK P.K., LEE C.H., KWON H.H.: Surface Modification of Nanofiltration Membranes to Improve the Removal of Organic Micro-Pollutants (EDC's and PhAC's) in Drinking Water Treatment: Graft Polymerization and Cross-Linking by Functional Group Substitution. J. Membr. Sci. 313 (1-2), 323-335 (2008).
29. KIM T.U., AMY G., DREWERS J.E.: Rejection of Trace Organic Compounds by High-Pressure Membranes. Water Sci. Technol. 51 (6-7), 335-344 (2005).
30. KOLPIN D. W., FURLONG E. T., MEYER M.T., THURMAN E. M., ZAUGG S.D., BARBER L. D., BUXTON H. T.: Pharmaceuticals, Hormones, and Other Organic Wastewater Contaminants in U. S. Streams, 1999-2000: A National Reconnaissance. Env. Sci. Technol., 36:1202-1211 (2002).
31. KURIYAMA S.Y.N., WANNER A., FIDELGO-NETO A.A., TALSNESS C.E., KOERNER W., CHAHOUD I.: Development Exposure to Low-Dose PBDE-99: Tissue Distribution and Thyroid Hormone Levels. Toxicologity 242 (1-3), 80-90 (2007).
32. LE NOIR M., PLIEVA F.M., MATTIASSON B.: Removal of Endocrine-Disrupting Compounds from Water Using Mesoporous Molecularly Imprinted Cryogels in a Moving-Bed Reactor. J.Sep.Sci. 32 (9) 1471-1479 (2009).
33. MCGOVERN P., MCDONALD H. S.: Endocrine Disruptors: The Nest Generation of Regular Concern?. Water Env. Technol., 15(1):35-39 (2003).
34. MULLER S.O.: Xenoestrogens: Mechanism of Action and Detection Methods. Anal. Bioanal. Chem. 378, 582-587 (2004).
35. OLMEZ-HANCI T., IMREN C., ARSLAN-ALATON I., KABDASLI I., TUNAY O.: H2O2/UV-C Oxidation of Potential Endocrine Disrupting Compounds: A Case Study with Dimethyl Phthtalate. Photochem. Photobiol. Sci. 8, 620-627 (2009).
36. ORTON F., LUTZ I., KLOAS W., ROUTLEDGE H.: Endocrine Disrupting Effects of Herbicides and Pentachlorophenols in vivo and in vitro evidence. Environ. Sci. Technol. 43 (6), 2144-2150 (2009).
37. PETROVIC M., ELJARRAT F., LOPEZ DE ALDA M.J., BARCELO D.: Endocrine Disrupting Compounds and Other Emerging Contaminants in the Environment : A Survey on new Monitoring Strategies and Occurrence Data. Anal. Bioanal. Chem. 378, 549-562 (2004).
38. POMATI F., CASTIGLIONI S., ZUCCATO E., FANELLI R., VIGETTI D., ROSSETI C., CALAMARI D., Environ. Sci. Technol. 2442, 2006.
39. PURDOM C.E., HARDIMAN P. A., BYE V. J., ENO N.C., TYLER C.R., SUMPTER J.P.: Estrogenic Effects of Effluents form Sewage Treatment Works. J. Chem. Ecol. 8, 275-285 (1994).
40. RICHTHOFF J., RYLANDER L., JOHNSSON B.A.G., AKESSON H., HAGMAR L., NILSSON E.P., STRIDSBERG M., GIWERCMAN A.: Se-rum levels of 2.2',4.4',5.5'-hexachlorobiphenyl (CB-153) in Relation to Markers of Reproductive Function in Young Males From the General Swedish Population. Environ. Health-Persp., 111 (4): 409-413 (2003).
41. SHAW I. AND MCCULLY S.: A Review of the Potential Impact of Dietary Endocrine Disruptors on the Consumer. Inter. J. Food Sci. Technol., 37(5):471-476 (2002).
42. SHON H.K., VIGNESWARAN S., SNYDER S.A.: Effluent Organic Matter (EfOM) in Waste Water; Constituents, Effects and Treatment. Crit. Rev. Environ. Sci. Technol. 36, 327-374 (2006).
43. SNYDER S., VANDERFORD B., PEARSON R. AND REXING D.: Analytical Methods for Measuring Endocrine Disruptors in Water. Proceedings Water Quality and Technology Conference. Seattle, Washington (November 2002).
44. SNYDER S., VANDERFORD B., PEARSON R., QUINONES O., YOON Y.: Analytical Method Used to Measure Endocrine Disrupting Compounds in Water. Pract. Period. Hazard. Toxic Radioactive Waste Manage, 7 (4) 224-234 (2003).
45. SNYDER S.A., KELLY K.A., GRANGE A.H., SOVOCOOL G.W., SNYDER E.M., GIESY J.P.: Pharmaceuticals and Personal Care Products in the Water of Lake Mead, Nevada. Pharmaceuticals and Personal Care Products in the Environment: Scientific and Regulatory Issues. in: Daughton, T.L., Jones-Lepp, T.I., (Eds.), American Chemical Society Symposium Series, Washington, DC, 2001, pp. 116-140.
46. SNYDER S.A., WESTERHOFF P., YOON Y., SEDLAK D.: Pharmaceuticals, Personal Care Products, and Endocrine Disruptors in Water: Implications for the Water Industry. Environ. Eng. Sci. 20, 449-469 (2003).
47. STRUMM-ZOLINGER E., FAIR G.M.: Biodegradation of Steroid Hormones. J. Water Pollut. Cont. Fed. 37, 1506-1510 (1965).
48. TABAK H.H., BUNCH R.L.: Steroid Hormones as Water Pollutants. I. Metabolism of Natural and Synthetic Ovaluation-Inhibiting Hormones by Microorganisms of Activated Sludge and Primary Settled Sewage. Dev. Ind. Microbiol. 11, 367-376 (1970).
49. TERNES T.A.: Occurrence of Drugs in German Sewage Treatment Plants and Rivers. Water Res., 1029:223-227 (1998).
50. TERNES T.A., MEISENHEIMER M., MCDOWELL D., BRAUCH H.J., BRIGITTE H.G., PREUSS G., WILLIAM U., ZULEI-SEIBERT N.: Removal of Pharmaceuticals During Drinking Water Treatment. Environ. Sci. Technol. 36, 3855-3863 (2002).
51. U.S. EPA, Aquatic Life Ambient Water Quality Criteria, Nonylphenol-Final Office of Water. 4304T. EPA-822-F-05-003, 2006.
52. U.S. EPA, Special Report on Environmental Endocrine Disruption: An Effects Assessment and Analysis, Office for Research and Development, Washington DC, EPA/630/R-36//012, February 1997.
53. VOLLMUTH S. AND NIESSNER R.: Degradation of PCDD, PCDF, PAH, PCB and Chlorinated Phenols During the Destruction Treatment of Landfill Seepage Water in Laboratory Model Reactor (UV, Ozone and UV/Ozone). Chemosphere, 30(12):2317-2331 (1995).
54. VON GUNTEN U., HUBER J., MCDOWELL D. AND TERNES T.: Oxidation of Pharmaceuticals During Ozonation: Kinetics and Product Formation. Abstract; Water Quality Technology Conference, American Water Works Association, Nov.1-6, 2003, Philadelphia, PA, USA, 2003.
55. WEN H.J., BERGENDAHL J.A., THOMPSON R.W.: Removal of Estrone from Water by Adsorption on Zeolites with Regeneration by Direct UV Photolysis. Environ. Eng. Sci. 26 (2), 319-326 (2009).
56. WESTERHOFF P., YOON Y., SNYDER S.: Effluent of Endocrine Disruptor, Pharmaceutical, and Personal Care Product Chemicals During Simulated Drinking Water Treatment Processes. Environ. Sci. Technol. 39, 6649-6663 (2005).
57. WEYER P. AND RILEY D.: Endocrine Disruptors and Pharmaceuticals in Drinking Water. American Water Works Association Research Fundation, Denver, Colorado (2001).
58. YAMAGUCHI A., AWANO T., OYAIZU K., YUASA M.: Surface Modified Mesoporous Silicas as Recycable Adsorbents of an Endocrine Disrupter, Bisphenol A. J.Nanosci.Nanotechnol. 6, 1989-1994 (2006).
59. YOON Y., WESTERHOFF P., SNYDER S.A., ESPARZA M.: HPLC-Fluorescence Detection and Adsorption of Bisphenol A, 17β-Estradiol, and 17α-Ethynyl Estradiol on Powdered Activated Carbon. Water Res. 37, 3530-3537 (2003).
60. YOON Y., WESTERHOFF P., SNYDER, S.A., WERT, E.C.: Nanofiltration and Ultrafiltration of Endocrine Disrupting Compounds, Pharmaceuticals and Personal Care Products. J. Membr. Sci. 270 (1-2), 88-100 (2006).
61. ZWEINER C. AND FRIMMEL F. H.: Oxidative Treatment of Pharmaceuticals in Water. Water Res., 34:1881-1885 (2000).

Typ dokumentu

Bibliografia

Identyfikator YADDA

bwmeta1.element.baztech-article-BPZ4-0016-0027